R3VIVE.ME 5-Amino-1MQ 50mg
R3VIVE.ME 5-Amino-1MQ 50mg is a research-grade small molecule designed for laboratory and scientific research involving nicotinamide N-methyltransferase (NNMT). Also known as 5-amino-1-methylquinolinium, 5-Amino-1MQ has attracted growing scientific interest because of its role as an NNMT inhibitor and its potential relevance to research into cellular metabolism, NAD+ pathways, adipose tissue biology and metabolic signalling.
This 50mg research product is intended for appropriately qualified researchers, laboratories and scientific professionals investigating the biological activity and characteristics of 5-Amino-1MQ. The compound should be treated as a research material rather than an approved medicine or nutritional product.
What Is R3VIVE.ME 5-Amino-1MQ 50mg?
R3VIVE.ME 5-Amino-1MQ 50mg contains 5-Amino-1MQ, a synthetic quinolinium-based small molecule studied for its ability to inhibit the enzyme nicotinamide N-methyltransferase, commonly abbreviated as NNMT.
NNMT is involved in the metabolism of nicotinamide and S-adenosylmethionine (SAM). Researchers have investigated this pathway because changes in NNMT activity can influence cellular methylation and NAD+-related metabolic processes.
Importantly, 5-Amino-1MQ is not a peptide. It is a small-molecule research compound that has primarily been investigated using laboratory and animal models. Current published evidence does not establish its safety, effectiveness or appropriate use in humans.
5-Amino-1MQ and NNMT Research
Interest in 5-Amino-1MQ comes largely from research into NNMT and its relationship with cellular metabolism. Experimental studies have examined NNMT inhibition in areas including adipocyte biology, energy metabolism, NAD+ availability and metabolic signalling.
Preclinical research has reported changes in metabolic markers following NNMT inhibition in experimental models. However, findings from cell cultures and animal studies cannot automatically be applied to humans.
For researchers, 5-Amino-1MQ provides a useful compound for investigating the NNMT pathway and understanding how manipulation of this enzyme may influence different biological processes. The existing literature remains an area of scientific investigation rather than established clinical evidence.
R3VIVE.ME 5-Amino-1MQ 50mg Research Applications
Researchers may investigate 5-Amino-1MQ in controlled laboratory environments when studying:
- NNMT enzyme activity
- Nicotinamide metabolism
- NAD+-related cellular pathways
- S-adenosylmethionine and methylation pathways
- Adipocyte and adipose-tissue biology
- Cellular metabolic signalling
- Experimental metabolic research
- Small-molecule inhibitor activity
The exact experimental application, concentration and research protocol should be determined by the relevant laboratory and qualified scientific personnel. Published animal protocols should not be interpreted as human dosing instructions.
Why Choose 5-Amino-1MQ 50mg?
The 50mg format provides a defined quantity of research material for laboratories conducting controlled investigations. R3VIVE.ME 5-Amino-1MQ 50mg is suitable for researchers who require a clearly identified compound for experimental work involving NNMT and related metabolic pathways.
When selecting research compounds, laboratories should consider product identification, batch information, analytical documentation, storage requirements and supplier quality controls. Where available, analytical documentation such as a Certificate of Analysis can help researchers assess the identity and quality of a particular batch.
5-Amino-1MQ Research Evidence
The scientific evidence surrounding 5-Amino-1MQ is still developing. Research identified to date is predominantly based on laboratory experiments and animal models, with no established body of controlled human clinical evidence demonstrating that 5-Amino-1MQ is safe or effective for weight management, metabolic conditions or other medical purposes.
This distinction is important for responsible scientific communication. Although experimental findings may provide useful information about NNMT inhibition, they should not be presented as proven human health benefits.
Storage and Laboratory Handling
5-Amino-1MQ should be handled according to the manufacturer’s product documentation and the requirements of the laboratory using the material. Appropriate laboratory procedures should be followed for storage, handling, preparation and disposal.
Researchers should consult the relevant product documentation before beginning any experiment and ensure that personnel handling the material are appropriately trained.
Is 5-Amino-1MQ Approved for Human Use?
5-Amino-1MQ should not be presented as an approved UK medicine or as a clinically established weight-loss treatment. Current research information indicates that the compound remains investigational, with evidence centred on preclinical studies rather than established human clinical trials.
UK businesses should also ensure that product descriptions, advertising and labelling comply with applicable UK requirements. The MHRA provides guidance concerning medicines and clinical-trial products in the UK, including requirements applicable to investigational medicinal products.
R3VIVE.ME 5-Amino-1MQ 50mg – Research Use Only
R3VIVE.ME 5-Amino-1MQ 50mg is presented for legitimate laboratory and research applications. It is not intended to diagnose, treat, cure or prevent any disease or medical condition. It is not a substitute for an authorised medicine, medical treatment or professional medical advice.
Researchers should use appropriate laboratory controls, follow institutional procedures and consult qualified professionals when designing experiments involving 5-Amino-1MQ.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ is a synthetic small molecule studied as an inhibitor of nicotinamide N-methyltransferase (NNMT).
Is 5-Amino-1MQ a peptide?
No. 5-Amino-1MQ is a small-molecule quinolinium compound, not a peptide.
What is 5-Amino-1MQ 50mg used for?
The 50mg quantity is intended for controlled research and laboratory investigations involving NNMT and related cellular metabolic pathways.
Has 5-Amino-1MQ been proven to work in humans?
No. The available evidence is predominantly preclinical, and established human clinical evidence is not currently available.
Is R3VIVE.ME 5-Amino-1MQ 50mg a medicine?
It should not be represented as an authorised medicine or clinically proven treatment.
Who should handle 5-Amino-1MQ?
Appropriately trained researchers and laboratory professionals should handle research compounds in accordance with relevant safety procedures and product documentation.
Important Research Disclaimer
R3VIVE.ME 5-Amino-1MQ 50mg is supplied as a research compound. It is not intended for human consumption, self-administration, diagnosis, treatment or prevention of disease. Research findings are provided for scientific and educational purposes and should not be interpreted as evidence of human safety or therapeutic effectiveness.
